Cheap put options and hedges: $AAPL puts cheaper than 100% of history, $MSFT 100%, $AMZN 100%, $GOOGL 100%, $FB 100%, $GILD 99%, $GOOG 99%
RT @StockTwits: Upcoming earnings
Tue - $GILD $DIS $TWLO
Wed - $YUM $WFM $TWX
Thu - $TWTR $NVDA $KO $P $DNKN $YELP
Fri - $AON
https://t.c…
Disney, Gilead, Mondelez All Slide After The Bell $DIS $GILD $MDLZ https://t.co/xMe9kmk9Pp
RT @Financial_Orbit: Successfully juggling the $GILD, $DIS & $MDLZ conf calls...but $YUMC kicks off at 7ET or midnight here...might leave t…
RT @theflynews: On The Fly: After Hours Movers $MYGN $COHR $MCHP $JIVE $PIR $PNRA $CNO $CTB $PCG $TDW $USNA $TCX $DRYS $Z $ZG $GILD… https:…
5 Stocks to Watch After the Market Closes Today - Feb. 7 $DIS $BWLD $GILD $PNRA $ZG Also $MRK https://t.co/NMnc4Ojs8T
RT @theflynews: On The Fly: After Hours Movers $MYGN $COHR $MCHP $JIVE $PIR $PNRA $CNO $CTB $PCG $TDW $USNA $TCX $DRYS $Z $ZG $GILD… https:…
RT @theflynews: On The Fly: After Hours Movers $MYGN $COHR $MCHP $JIVE $PIR $PNRA $CNO $CTB $PCG $TDW $USNA $TCX $DRYS $Z $ZG $GILD… https:…
RT @theflynews: On The Fly: After Hours Movers $MYGN $COHR $MCHP $JIVE $PIR $PNRA $CNO $CTB $PCG $TDW $USNA $TCX $DRYS $Z $ZG $GILD… https:…
RT @theflynews: On The Fly: After Hours Movers $MYGN $COHR $MCHP $JIVE $PIR $PNRA $CNO $CTB $PCG $TDW $USNA $TCX $DRYS $Z $ZG $GILD… https:…
RT @bio_clouseau: $GILD just couldn't think of anything better to do with 11B in 2016 https://t.co/FFKZh99TDN
RT @tgtxdough: $CELG has a 2020 plan $GILD 2020 plan - who the heck knows. Pitiful. $CELG much better value longterm imho https:/…
RT @DrSManian: $GILD https://t.co/d2STm8lXmn
RT @adamfeuerstein: $GILD total product sales guidance for 2017:
$22.5 — $24.5B
non HCV $15-$15.5B
HCV $7.5-9B
That, my friends, is WAY b…
RT @adamfeuerstein: $GILD cash $32.38 billion.
RT @adamfeuerstein: $GILD concedes will be difficult to grow revenue off $30B (2016) base without acquisition(s).
Good question, Mark Sch…
$GILD made a lot of money curing patients of an awful disease. The technology was ripe. If they didn't do it, someo… https://t.co/KkIZrDeYaT
RT @BioStockAddict: Filgotinib timelines from $GILD 's ER. #Galapagos $GLPG https://t.co/6omD7ZWrff
RT @BiotechRadar: Gilead #NASH slides $GILD https://t.co/yn9pgv11m5
RT @adamfeuerstein: Thinking more about $GILD. Perhaps the awful, brutally honest lesson here is: Curing disease is great for patients but…
$GILD persistent downtrend continues to drive price lower https://t.co/mQdoWtujr9 https://t.co/95sMUDEM9V
#Gilead FY 2017 Hepatitis C Drug Sales Guidance Misses $GILD https://t.co/Q6PCxPMTUB
@adamfeuerstein Are cured $GILD patients now amenable to therapies for other comorbidities (or were these peeps alr… https://t.co/ZFXDLfJj3T
RT @Biohazard3737: Maybe, they should just announce their plan to build a $35k electric car and hire a CEO with ADHD. $GILD $TSLA https://t…
RT @adamfeuerstein: Thinking more about $GILD. Perhaps the awful, brutally honest lesson here is: Curing disease is great for patients but…
RT @BioStockAddict: $GLPG $GILD standstill always rumoured to end at YE 2017. #Galapagos #Filgotinib https://t.co/x2UOxICTrL
$GILD Gross incompetence, waste of resources, undeserved compensation #milliganmustgo
RT @BiotechHack: $GILD could a number this bad actually move Smid cap higher? They clearly need to buy something to help move the needle..…
my friend just sent me this after i showed him the $GILD chart https://t.co/PSZXR01JHg
RT @MugatuCapital: Hypothesis: $GILD mgmt/culture is trapped by valuations vs M&A. Will not do deal. Will bleed out to $45-55/shr, and then…
RT @CGrantWSJ: $GILD has earned a reputation for excellent capital allocation. They are showing what they think of small and mid cap valuat…
RT @adamfeuerstein: Thinking more about $GILD. Perhaps the awful, brutally honest lesson here is: Curing disease is great for patients but…
#GileadSciences Just Kitchen-Sinked 2017 Guidance, Worse Than Anyone Expected. Read more: https://t.co/aOPMlDQskL $GILD
RT @adamfeuerstein: Thinking more about $GILD. Perhaps the awful, brutally honest lesson here is: Curing disease is great for patients but…
$GILD:,Solid Earnings, Too Bad About the Guidance; Is This a ‘Clearance Event?’ - Barron's https://t.co/2Rq6iDHYgW
Btw, Estimated #Earnings Per Share for $GILD is $2.62 it's 3.62% of the current price https://t.co/ITADQ4t2vr
$GILD still made great ROI from Sovaldi, even w/ $11B into Pharmasset. Investor expectations were unrealistic: No f… https://t.co/fQSa3KVJc2
@bentedges @MugatuCapital $45-55 on $gild is low however $60 by 2018 if revs continue declining is very feasible could see $90 on BO offer.
RT @ChartTrending: $GILD March 67.5/70 puts total 10500 puts in OI, they will make a fortune tomorrow! call buyers will be bag holders!
Is It Time To Get Defensive? – $GILD $PG $WMT $CL https://t.co/1RWUMyY0RG
Why GILD Is DOWN In After Hours Trading Gilead Sciences Earnings Results https://t.co/LEAaeOmJfG $GILD
$gild Would be crazy not to buy $myl now and get the #1 generics co in the world selling at 10x's earnings. CF would be a home run for them.
RT @The_Real_Fly: Worst thing $GILD ever did was cure hep c. That'll teach them. Next time, they'll look for a 'treatment'
RT @adamfeuerstein: Thinking more about $GILD. Perhaps the awful, brutally honest lesson here is: Curing disease is great for patients but…
$GILD ’s income driven down by lower sales of hepatitis C virus products https://t.co/VgPkH8SYhu
RT @nixon786: $GILD meds that cures disease are always good for business. see how much $GILD made after buying $VRUS for $11B... chart by @…
RT @The_Real_Fly: Worst thing $GILD ever did was cure hep c. That'll teach them. Next time, they'll look for a 'treatment'
Gilead Sciences ALONE is valued at aprox 96 Billion
That is just ONE company. $GILD
so try again. https://t.co/TZgMy7w3vx
@CGrantWSJ To bad they are borrowing - giving away borrowed cash. $gild - check out Longterm Liabiliies up $5.7 Bil… https://t.co/njqcq9YYyg
$PFE plans on selling 2 billion in assets is that one of the buys $GILD plans on making, $PFE $GILD CEO's did have a meeting at a conf $IBB
Yes $GILD in trouble with$30B in cash and 22B in annual Revs. Look elsewhere maybe $SHLD ? https://t.co/p0qpvmXeXd
RT @The_Real_Fly: Worst thing $GILD ever did was cure hep c. That'll teach them. Next time, they'll look for a 'treatment'
#GileadSciences Gilead HCV outlook souring. Read more: https://t.co/srRvPc1GCu $GILD
RT @getvolatility: Cheap put options and hedges: $AAPL puts cheaper than 100% of history, $MSFT 100%, $AMZN 100%, $GOOGL 100%, $FB 100%, $G…
vitaliyk: RT The_Real_Fly: Worst thing $GILD ever did was cure hep c. That'll teach them. Next time, they'll look for a 'treatment'
RT @The_Real_Fly: Worst thing $GILD ever did was cure hep c. That'll teach them. Next time, they'll look for a 'treatment'
$GILD - a lot of put open interest at $70 - they want to get paid so not surprised to see stab below this key support level
$GILD generated $11B in 4 Q and 4X $VRUS purchase price in 5yr..
@adamfeuerstein did not have good drink today. https://t.co/hXapITZ18Q
RT @adamfeuerstein: Thinking more about $GILD. Perhaps the awful, brutally honest lesson here is: Curing disease is great for patients but…
RT @adamfeuerstein: Thinking more about $GILD. Perhaps the awful, brutally honest lesson here is: Curing disease is great for patients but…
1 bullish takeaway from Gilead's seemingly horrible earnings & guidance, $GILD | https://t.co/Kqgr4V3pTD
$GILD In Trouble...
@chrispycrunch $GILD
@TVarmageddon yep. I never bought $TEVA but its on my list. $GILD I just watch in amazement.
Waiting for Trump to retweet a fact like this, starting the (necessary) "negotiating Medicare" discussion and subse… https://t.co/IAvB8z7gwD
Can #Gilead Cure The #Earnings Season Blues? $GILD https://t.co/BN7xsKcN10
Gilead: Dreadful Guidance Inspires Fear $GILD https://t.co/N1VqtOYPSO
$GILD meds that cures disease are always good for business. see how much $GILD made after buying $VRUS for $11B...… https://t.co/DYXXANc45e
RT @adamfeuerstein: Thinking more about $GILD. Perhaps the awful, brutally honest lesson here is: Curing disease is great for patients but…
RT @PortfolioArmor: As we noted before its earnings release, institutions had been selling Gilead in dark pools all year. $GILD https://t.c…
As we noted before its earnings release, institutions had been selling Gilead in dark pools all year. $GILD https://t.co/ljPTNtmZcY
@john_turnipseed @whitleytrading @OptimizedValue in $GILD?
@HarvestInvestor was about to say...is this a subtweet of us $GILD bagholders?
@McDoy5 @DominicG64 ask the 'big' company $gild how their business is doing. They are all desperate. To the point they give $$ to criminals
@adamfeuerstein Nah, they just need to get their BD&L game together, $GILD will find a way to spend Sovaldi $ effectively... eventually
@fezziwig2008 $gild is listening about the value of #pegph20 and the rest of the platform at $halo - total buy!
RT @adamfeuerstein: Thinking more about $GILD. Perhaps the awful, brutally honest lesson here is: Curing disease is great for patients but…
@adamfeuerstein Gene therapy companies won't have $GILD HCV problem: too much revenue generated initially, impossible to make up quickly.
RT @fezziwig2008: $GILD has tried and failed at treating #Pancreatic Cancer for years - what acquisition does that bring to mind? $HALO -ma…
RT @adamfeuerstein: Thinking more about $GILD. Perhaps the awful, brutally honest lesson here is: Curing disease is great for patients but…
@Mad_Scientist2 As usually, he is just tweeting like idiot. Nothing new, here. $GILD
RT @lancejepsen: Gilead Sciences Beats on Earnings and Revenue $GILD #stockmarket #stocktrading https://t.co/R0p6TpXRk2 https://t.co/XXEg3g…
And in addition to that, where a cure is even remotely feasible, if you don't cure, your competitor will. $GILD https://t.co/cRSx2iwf3k
RT @zbiotech: $GILD adj EPS/rev as of close
'17: $10.73/28B
'18: $10.28/26.2B
'19: $10.60/26B
'20: $10.97/25.4B
Trading Watch List - 02.08.17: https://t.co/6GKJSDtnvz
#Trading #stocks
$SPY $MCHP $COHR $GILD $BWLD $CXRX $MYGN… https://t.co/PMpNAqJGcn
But this simply isn't true. $GILD would be much worse off had they never got involved with HCV. https://t.co/XkufrO4v8q
RT @ChartTrending: $GILD March 67.5/70 puts total 10500 puts in OI, they will make a fortune tomorrow! call buyers will be bag holders!
@CGrantWSJ and the mkt is appropriately revaluing $GILD on lower EPS, revs & cash flow. Hard to move a mega-cap with a declining picture
RT @adamfeuerstein: Thinking more about $GILD. Perhaps the awful, brutally honest lesson here is: Curing disease is great for patients but…
@MugatuCapital not sarcastic. not being a jerk. Just stating that your thoughts on $GILD are incorrect.
RT @adamfeuerstein: Thinking more about $GILD. Perhaps the awful, brutally honest lesson here is: Curing disease is great for patients but…
RT @adamfeuerstein: Thinking more about $GILD. Perhaps the awful, brutally honest lesson here is: Curing disease is great for patients but…
adamfeuerstein: Thinking more about $GILD. Perhaps the awful, brutally honest lesson here is: Curing disease is great for patients but suck…
Gilead Sciences Beats on Earnings and Revenue $GILD #stockmarket #stocktrading https://t.co/R0p6TpXRk2 https://t.co/XXEg3ghwV8
RT @adamfeuerstein: Thinking more about $GILD. Perhaps the awful, brutally honest lesson here is: Curing disease is great for patients but…
RT @adamfeuerstein: Thinking more about $GILD. Perhaps the awful, brutally honest lesson here is: Curing disease is great for patients but…
RT @adamfeuerstein: Thinking more about $GILD. Perhaps the awful, brutally honest lesson here is: Curing disease is great for patients but…
RT @adamfeuerstein: Thinking more about $GILD. Perhaps the awful, brutally honest lesson here is: Curing disease is great for patients but…
RT @adamfeuerstein: Thinking more about $GILD. Perhaps the awful, brutally honest lesson here is: Curing disease is great for patients but…
RT @adamfeuerstein: Thinking more about $GILD. Perhaps the awful, brutally honest lesson here is: Curing disease is great for patients but…
@Bamabroker $GILD cheap if earnings are bottoming & they acquire with all their cash. Risk / reward interesting @$70
Thinking more about $GILD. Perhaps the awful, brutally honest lesson here is: Curing disease is great for patients but sucks for business.
@haodongvli $GILD wants a $30 billion drug that they pay $10 billion for... the problem is they are once a decade products.
Trading Watch List - 02.08.17: https://t.co/6GKJSDtnvz
#Trading #stocks
$SPY $MCHP $COHR $GILD $BWLD $CXRX $MYGN… https://t.co/buKVfteuwH
RT @theflynews: On The Fly: After Hours Movers $MYGN $COHR $MCHP $JIVE $PIR $PNRA $CNO $CTB $PCG $TDW $USNA $TCX $DRYS $Z $ZG $GILD… https:…
Biotech Movers 02/07:
$CHRS $GALE offering
$GILD earnings
$KTOV halt
Pipeline updates
$FLXN PDUFA 10/6
$AMGN $GWPH
https://t.co/kmcBTBnalU
Stochastic OB https://t.co/GrIFelG4Av $CAH $LPX $WY $GILD $VTI $USG $FOLD $NFLX $PSEC $PCY $AGI $FNSR $IBM $WDAY $RF $UPRO $BIOS
RT @The_Real_Fly: Worst thing $GILD ever did was cure hep c. That'll teach them. Next time, they'll look for a 'treatment'
Trading Watch List - 02.08.17: https://t.co/6GKJSDKYn7
#Trading #stocks
$SPY $MCHP $COHR $GILD $BWLD $CXRX $MYGN… https://t.co/7buhE1VKHm
Side note on $GILD - still in best position if we have a material sell off on sector or market. Sort of an embedded put / call on mkt.
RT @adamfeuerstein: Thinking more about $GILD. Perhaps the awful, brutally honest lesson here is: Curing disease is great for patients but…
CS:" $GILD Big stepdown in '17 HCV guidance; M&A is the driver of upside from here; lowering TP from $93 to $79." https://t.co/YQPRAPhmfw
@TomSilver39 $GILD Reiterate OW, TP=$95..."
Piper" $GILD Further You Fall,Closer You Are To Bottom;It stinks--but if you hold your nose, it's not that bad;So much room for P/E to grow"
MS: $GILD guide surprises even us. On +ve side, the faster HCV falls, easier to move rev needle higher w/ deal. Remain EW. PT $77 (from $85)
Man it's #late. I'm up. You're up. You should check out these top 5 trending #stocks. $DRYS $GILD $TWLO $NVDA $SHLD #tahonta
#GileadSciences Why Gilead Earnings Were Not Up to Snuff. Read more: https://t.co/Bu8lMTyfsX $GILD
Gilead Q4 income down, mainly due to fall in hepatitis C virus products sale
https://t.co/acGVJ3Wl5F
#hepatitisC $GILD
RT @TomSilver39: CS:" $GILD Big stepdown in '17 HCV guidance; M&A is the driver of upside from here; lowering TP from $93 to $79." https://…
Btw, Estimated #Earnings Per Share for $GILD is $2.62 it's 3.58% of the current price https://t.co/ITADQ4t2vr
RT @MaxNisen: $GILD says M&A its top priority this year, reducing buybacks (more aggressive language on BD than in past)
$GILD -6% $DIS -1.5% $MDLZ -3% $TWLO -1% After Hours.
$GILD Fails To Impress Yet Again https://t.co/EPy3589B1u
$GILD Just Kitchen-Sinked 2017 Guidance, Worse Than Anyone Expected https://t.co/cVsHkBQ5BQ
RT @prolifebuttons: Gilead Sciences ALONE is valued at aprox 96 Billion
That is just ONE company. $GILD
so try again. https://t.co/TZgMy7w3…
RT @AntounNabhan: $GILD still made great ROI from Sovaldi, even w/ $11B into Pharmasset. Investor expectations were unrealistic: No franchi…
RT @adamfeuerstein: Thinking more about $GILD. Perhaps the awful, brutally honest lesson here is: Curing disease is great for patients but…
RT @TomSilver39: @TomSilver39 $GILD Reiterate OW, TP=$95..."
RT @TomSilver39: Piper" $GILD Further You Fall,Closer You Are To Bottom;It stinks--but if you hold your nose, it's not that bad;So much roo…
@tgtxdough solution is for $GILD to merge with $CELG, stop buybacks & use excess cash to buy numerous biotech cos & double celg pipeline
Will #Gilead Get Its Comeuppance Today? $GILD Also $MNK $VRX https://t.co/eUniTQ3skg
RT @tgtxdough: $CELG has a 2020 plan $GILD 2020 plan - who the heck knows. Pitiful. $CELG much better value longterm imho https:/…
Why GILD Is DOWN In After Hours Trading Gilead Sciences Earnings Results https://t.co/LEAaeOmJfG $GILD
An $IBB $XBI solution
$CELG buys $OMED $XLRN $HALO
$GILD buys $ZIOP $KPTI $SGMO $TGTX
@Celgene & @GileadSciences #merge
Do you agree?
RT @Biotech2050: @tgtxdough solution is for $GILD to merge with $CELG, stop buybacks & use excess cash to buy numerous biotech cos & double…
$GILD RBC CUTS PT TO $75 FROM $90
CITI New guidance could create new floor, Neutral $76 TP
MORGAN STANLEY CUTS PT TO $77 FROM $85
RT @adamfeuerstein: Thinking more about $GILD. Perhaps the awful, brutally honest lesson here is: Curing disease is great for patients but…
RT @adamfeuerstein: Thinking more about $GILD. Perhaps the awful, brutally honest lesson here is: Curing disease is great for patients but…
RT @BioStockAddict: $GLPG $GILD standstill always rumoured to end at YE 2017. #Galapagos #Filgotinib https://t.co/x2UOxICTrL
RT @pulpmarkets: vitaliyk: RT The_Real_Fly: Worst thing $GILD ever did was cure hep c. That'll teach them. Next time, they'll look for a 't…
RT @TomSilver39: CS:" $GILD Big stepdown in '17 HCV guidance; M&A is the driver of upside from here; lowering TP from $93 to $79." https://…
RT @EJLandis: Gilead, Church & Dwight Boost Dividends $GILD $CHD #investing #dividends https://t.co/zTWv0wQ12l https://t.co/Ym350TNTCT
Gilead, Church & Dwight Boost Dividends $GILD $CHD #investing #dividends https://t.co/zTWv0wQ12l https://t.co/Ym350TNTCT
Gilead Sciences, Inc. $GILD Releases Earnings Results, Beats Estimates By $0.09 EPS https://t.co/Fb3uWzYWID
$GILD You know what to do Milligan - time for some $TSRO on your portfolio. #stocks #trade #invest
$GILD 65% EBITDA margins are still some of the highest among biotech companies $PFE $AMGN $BMY $JNJ #stocks… https://t.co/uIUbau6pjA
$GILD Q4 2016 Earnings Call Audio is now available #earnings https://t.co/jSOpMJasda
https://t.co/ZpCMK1WIFa // Stock market scanners update using MTFA - TICKER:... // $GILD #trading #investing #stocks https://t.co/nYsY7eHoeF
Genfit $GNFT $ICPT $GILD #NASH
Not to be Underestimated: What's the Hype around NASH? via @labiotech_eu
https://t.co/ONhi7egfXK
#GileadSciences Gilead Crashes On Hep C Sales Decline, 2017 Views; Q4, 2016 Metrics Top. Read more: https://t.co/xaKWWHxW1t $GILD
RT @InterestRateArb: cmon $gild make biotech great again
#GileadSciences Gilead's quarterly profit falls, lower sales expected in 2017. Read more: https://t.co/k5uFkTxt0v $GILD
Stochastic OB https://t.co/GrIFelG4Av $CAH $LPX $WY $GILD $VTI $USG $FOLD $NFLX $PSEC $PCY $AGI $FNSR $IBM $WDAY $RF $UPRO $BIOS
RT @adamfeuerstein: Thinking more about $GILD. Perhaps the awful, brutally honest lesson here is: Curing disease is great for patients but…
3 Crucial Questions #GileadSciences Should Answer Tuesday. Read more: https://t.co/aZVxDBOULe $GILD
RT @BioStockAddict: $GLPG $GILD standstill always rumoured to end at YE 2017. #Galapagos #Filgotinib https://t.co/x2UOxICTrL
#GileadSciences Gilead stock sinks 3.5% on disappointing 2017 sales guidance. Read more: https://t.co/l9SJo8dSuM $GILD
#GileadSciences Gilead stock sinks 3.5% on disappointing 2017 sales outlook. Read more: https://t.co/Ym4B16MZdg $GILD
$GILD Harvoni sales continue their decline from $1.86bn in Q3 to $1.64bn in Q4 as #HCV patient starts fall further #pharma
RT @lancejepsen: Gilead Sciences Beats on Earnings and Revenue $GILD #stockmarket #stocktrading https://t.co/R0p6TpXRk2 https://t.co/XXEg3g…
$GILD shall lead the way today https://t.co/KsS3RmMSZX
RT @adamfeuerstein: Thinking more about $GILD. Perhaps the awful, brutally honest lesson here is: Curing disease is great for patients but…
Commented on Gilead: Dreadful Guidance Inspires Fear https://t.co/ciZXTFtqvJ $GILD
RT @DrSManian: $GILD https://t.co/d2STm8lXmn
$GILD Q4 And Full Year 2016 Earnings Presentation is now available #earnings https://t.co/1SZglqAfg7
$GILD shall lead the way
$GILD:
Gilead Sciences (GILD) PT Lowered to $77 at Morgan Stanley:
https://t.co/OrJFRGMJ0t
$GILD is done eh. Interesting the PT's are lowered but still trying to negotiate an orderly exit for the bigger players. This should be $50
$GILD downgraded at Citi, MSCO cutting PT buy $8 to $77, RBC chops PT from $90 to $77
$GILD: The forecast EPS for Gilead Sciences, Inc. has decreased to $10.58 from $11.41 in the last week. (https://t.co/QcNBDfJD1o)
RT @BlacklistTrader: $GILD shall lead the way today https://t.co/KsS3RmMSZX
Good news for $GILD is continued strong uptake of Epclusa in #HCV GT-2/3 patients ($1.05bn) in Q4 while $BMY Daklinza plunges to $221m
Gilead Sciences, Inc. $GILD PT Set at $100.00 by Cowen and Company https://t.co/ChgnBVnNM0
Value guys loved this one ... oops $GILD https://t.co/inPH1UIeYC
RT @odibro: $GILD Q4 HCV product sales $3.2B vs. $4.9B last year
RT @bio_clouseau: $GILD predicts 1.9-2.5B of its 2016 HCV share going to competition in 2017 $ABBV $MRK $ENTA https://t.co/q0XVCjdsGU
Per CNBC: Most exposure to Medicare (in order): $GILD $AZN $SNY $REGN $RHHBY $AMGN
** $CELG has much lower exposure to Medicare
$IBB $XBI
RT @chessNwine: NEW POST: Stock Market Recap 02/07/17 {Video} https://t.co/DKwx4NYw6l $BWLD $DRYS $DIS $GILD $TWLO
Will #Gilead Get Its Comeuppance Today? $GILD Also $MNK $VRX https://t.co/E8gE9ZLNyq
$GILD GILD result does not bode for the sector $BMY BMY run up may halt as well